Cargando…

The use of angiotensin receptor blockers in dementia prevention

Alzheimer’s disease (AD) and dementia are preventable and highly prevalent diseases, as is systemic arterial hypertension. Thus, it is speculated that angiotensin receptor blockers (ARBs) may be neuroprotective against AD. OBJECTIVE: The aim of this study was to evaluate if the use of ARBs confers a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Müller, Jordana de Araujo, Giacobe, Laura Jacques, Grassi, Vanise, Palmeira, André Luiz Rodrigues
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Academia Brasileira de Neurologia, Departamento de Neurologia Cognitiva e Envelhecimento 2023
Materias:	View & Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10481907/ https://www.ncbi.nlm.nih.gov/pubmed/37681194 http://dx.doi.org/10.1590/1980-5764-DN-2023-3006

Ejemplares similares

Chronic insomnia disorder as risk factor for stroke: a systematic review
por: Silva, Luiz Augusto Soares, et al.
Publicado: (2022)

Angiotensin-Converting Enzyme Inhibitors, Angiotensin Receptor Blockers, and COVID-19: Demonstrating the Actionability of Real-World Evidence
por: Hennessy, Sean, et al.
Publicado: (2020)

Angiotensin II Receptor Blockers in the Management of Hypertension in Preventing Cognitive Impairment and Dementia—A Systematic Review
por: D’Silva, Elvira, et al.
Publicado: (2022)

Angiotensin receptor blocker add-on therapy in portal hypertension: To use angiotensin receptor blocker or not to use, that is the question
por: Lee, Hyun Woong
Publicado: (2014)

A combined role of calcium channel blockers and angiotensin receptor blockers in stroke prevention
por: Wang, Ji-Guang
Publicado: (2009)

The SARS-CoV-2 receptor, ACE-2, is expressed on many different cell types: implications for ACE-inhibitor- and angiotensin II receptor blocker-based cardiovascular therapies
por: Albini, Adriana, et al.
Publicado: (2020)

Receptor Interactions of Angiotensin II and Angiotensin Receptor Blockers—Relevance to COVID-19
por: Moore, Graham J., et al.
Publicado: (2021)

Angiotensin receptor blockers and COVID-19
por: Saavedra, Juan M.
Publicado: (2020)

Angiotensin receptor blocker neprilysin inhibitors
por: Usuda, Daisuke, et al.
Publicado: (2021)

Angiotensin II receptor blockers in the prevention of complications from atrial fibrillation
por: Naccarelli, Gerald V, et al.
Publicado: (2009)

Angiotensin receptor blockers and risk of dementia: cohort study in UK Clinical Practice Research Datalink
por: Goh, Kah L, et al.
Publicado: (2015)

Use of angiotensin receptor blockers and risk of dementia in a predominantly male population: prospective cohort analysis
por: Li, Nien-Chen, et al.
Publicado: (2010)

Calcium channel blockers, angiotensin receptor blockers, and angiotensin-converting enzyme inhibitors: Effectiveness in combination with diuretics or β-blockers for treating hypertension
por: Bisognano, John D, et al.
Publicado: (2007)

Angiotensin receptor blockers for prevention of cardiovascular disease: where does the evidence stand?
por: Fuchs, Flávio Danni, et al.
Publicado: (2015)

Potential use of angiotensin receptor blockers in skin pathologies
por: Hedayatyanfard, Keshvad, et al.
Publicado: (2023)

COVID-19, Angiotensin Receptor Blockers, and the Brain
por: Saavedra, Juan M.
Publicado: (2020)

Premorbid Use of Beta-Blockers or Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers in Patients with Acute Ischemic Stroke
por: Zeng, Yuanyuan, et al.
Publicado: (2023)

Pneumonia Risk and Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers
por: Liu, Chia-Lin, et al.
Publicado: (2013)

Fracture Risk and Use of Angiotensin-Converting Enzyme Inhibitors or Angiotensin II Receptor Blockers
por: Holloway-Kew, Kara L., et al.
Publicado: (2022)

Angiotensin Receptor Blocker for Stroke Prevention in Atrial Fibrillation: beyond Blood Pressure Lowering?
por: Choi, Eue-Keun
Publicado: (2016)

The Fetal Safety of Angiotensin Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers
por: Moretti, Myla E., et al.
Publicado: (2012)

Effect of angiotensin converting enzyme inhibitors and angiotensin receptor blockers on hemoglobin levels
por: Ajmal, Adnan, et al.
Publicado: (2013)

Association Between Angiotensin-Converting Enzyme Inhibitors, Angiotensin Receptor Blockers, and Suicide
por: Mamdani, Muhammad, et al.
Publicado: (2019)

Effects of angiotensin receptor blockers and angiotensin-converting enzyme inhibitors on COVID-19
por: Li, Xiao-Long, et al.
Publicado: (2021)

Renin-angiotensin system inhibition in COVID-19 patients
por: de Vries, A. A. F.
Publicado: (2020)

Beta-blockers in atrial fibrillation—trying to make sense of unsettling results
por: Meyer, Markus, et al.
Publicado: (2023)

Long-Term Use of Angiotensin Receptor Blockers and the Risk of Cancer
por: Azoulay, Laurent, et al.
Publicado: (2012)

Generic Statins and Angiotensin Receptor Blockers: Are They Really Useful in Ebola?
por: Wiwanitkit, Viroj
Publicado: (2016)

Vascular dementia: Diagnostic criteria and supplementary exams. Recommendations of the Scientific Department of Cognitive Neurology and Aging of the Brazilian Academy of Neurology. Part I
por: Engelhardt, Eliasz, et al.
Publicado: (2011)

Vascular dementia: Cognitive, functional and behavioral assessment. Recommendations of the Scientific Department of Cognitive Neurology and Aging of the Brazilian Academy of Neurology. Part II
por: Engelhardt, Eliasz, et al.
Publicado: (2011)

Reappraisal of role of angiotensin receptor blockers in cardiovascular protection
por: Ram, C Venkata S
Publicado: (2011)

Angiotensin receptor blocker-induced bilateral ciliochoroidal effusion
por: Aggarwal, Kanika, et al.
Publicado: (2020)

Angiotensin Receptor Blockers Associated Enteropathy-Brief Report
por: Gosai, Neha, et al.
Publicado: (2022)

Angiotensin II Receptor Blockers and Arrhythmias in Ventricular Hypertrophy
por: Salama, Guy
Publicado: (2022)

Clinical Pharmacogenetics of Angiotensin II Receptor Blockers in Iraq
por: Al-Hussaniy, Hany A., et al.
Publicado: (2023)

Angiotensin Receptor Blockers Upregulate Angiotensin Type 4 Receptor in Brains of Cognitively Intact Individuals
por: Cosarderelioglu, Caglar, et al.
Publicado: (2021)

Teaching medical students about dementia: A brief review
por: Jacinto, Alessandro Ferrari, et al.
Publicado: (2015)

The dementias of schizophrenia
por: de Oliveira-Souza, Ricardo, et al.
Publicado: (2007)

The controversy of using angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in COVID-19 patients
por: Harky, Amer, et al.
Publicado: (2021)

Angiotensin II receptor blocker or angiotensin-converting enzyme inhibitor use and COVID-19-related outcomes among US Veterans
por: Derington, Catherine G., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_q7p636pgepehhq1n07t0sjn6ol